Expertise in
4
conditions

Dr. Min K. Kim

Oral and Maxillofacial Surgery
Office
1201 Main St Unit 3, 
Tewksbury, MA 
Accepting New Patients
Expertise in
4
conditions
Office
1201 Main St Unit 3, 
Tewksbury, MA 

Overview

Min Kim is an Oral and Maxillofacial Surgeon practicing medicine in Tewksbury, Massachusetts.

Dr. Kim is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Febrile Neutropenia, Menopause, PIK3CA-Related Overgrowth Spectrum, Thyroidectomy, and Hormone Replacement Therapy (HRT).

She is actively involved in clinical research, co-authoring 524 peer reviewed articles and participating in 6 clinical trials. Dr. Kim is currently accepting new patients.

Specialties

Oral and Maxillofacial Surgery

Licenses

Oral & Maxillofacial Surgery in MA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Office
1201 Main St Unit 3, Tewksbury, MA 01876

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Enrollment Status: Active_not_recruiting
Publish Date: November 26, 2025
Intervention Type: Drug
Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone
Study Phase: Phase 3
Phase 2 Study of Autologous Hematopoietic Cell Transplantation for Core-binding Factor Positive Acute Myeloid Leukemia in the First Complete Remission
Phase 2 Study of Autologous Hematopoietic Cell Transplantation for Core-binding Factor Positive Acute Myeloid Leukemia in the First Complete Remission
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Multi-center,Open, Longitudinal, Observational Study to Evaluate the Treatment Effectiveness and Safety of the Bortezomib-melphalan-prednisolone Regimen in Treatment-naïve Patients With Multiple Myeloma, Ineligible for Hematopoietic Transplantation
A Multi-center,Open, Longitudinal, Observational Study to Evaluate the Treatment Effectiveness and Safety of the Bortezomib-melphalan-prednisolone Regimen in Treatment-naïve Patients With Multiple Myeloma, Ineligible for Hematopoietic Transplantation
Enrollment Status: Completed
Publish Date: June 15, 2023
Public-interest Multicenter Umbrella Trial Based on Genetic Analysis in Korean Head and Neck Cancer and Esophageal Cancer Patient - Part 1 (HNSCC)]
Public-interest Multicenter Umbrella Trial Based on Genetic Analysis in Korean Head and Neck Cancer and Esophageal Cancer Patient - Part 1 (HNSCC)]
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Drug
Study Drugs: BYL719, Poziotinib, Nintedanib, Abemaciclib, Durvalumab, Tremelimumab
Study Phase: Phase 2
A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Enrollment Status: Terminated
Publish Date: December 12, 2018
Intervention Type: Drug
Study Phase: Phase 3
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Enrollment Status: Unknown
Publish Date: July 24, 2018
Intervention Type: Drug
Study Drugs: Rituximab, Modified VPDL
Study Phase: Phase 2
View 5 Less Clinical Trials

524 Total Publications

Dissemination of blaKPC-3-harbouring Klebsiella pneumoniae across ST48 and ST628 in multiple healthcare facilities in the Republic of Korea.
Dissemination of blaKPC-3-harbouring Klebsiella pneumoniae across ST48 and ST628 in multiple healthcare facilities in the Republic of Korea.
Journal: Emerging microbes & infections
Published: September 01, 2026
Similar Doctors
Expertise in
10
conditions
Dr. Cory M. Resnick
Oral and Maxillofacial Surgery
Expertise in
10
conditions
Dr. Cory M. Resnick
Oral and Maxillofacial Surgery
Referral may be required

Department Of Plastic And Oral Surgery

319 Longwood Ave, 
Boston, MA 
 (19.9 miles away)
857-218-6422
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Cory Resnick is an Oral and Maxillofacial Surgeon practicing medicine in Boston, Massachusetts. Dr. Resnick is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Acrofacial Dysostosis Nager Type, Temporomandibular Ankylosis, Acrofacial Dysostosis Weyers Type, Osteotomy, and Gastrostomy. Dr. Resnick is currently accepting new patients.

Expertise in
7
conditions
Dr. Zachary S. Peacock
Oral and Maxillofacial Surgery
Expertise in
7
conditions
Dr. Zachary S. Peacock
Oral and Maxillofacial Surgery
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (19.0 miles away)
617-726-2740
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Zachary Peacock is an Oral and Maxillofacial Surgeon practicing medicine in Boston, Massachusetts. Dr. Peacock is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Fibrous Dysplasia, Myhre Syndrome, Arrhinia, Osteotomy, and Bone Graft. Dr. Peacock is currently accepting new patients.

Expertise in
3
conditions
Dr. Leonard B. Kaban
Oral and Maxillofacial Surgery
Expertise in
3
conditions
Dr. Leonard B. Kaban
Oral and Maxillofacial Surgery
Referral may be required

Carlos Fernandez-Del Castillo MD

15 Parkman St, 
Boston, MA 
 (19.0 miles away)
617-726-2740
Languages Spoken:
English
See accepted insurances

Leonard Kaban is an Oral and Maxillofacial Surgeon practicing medicine in Boston, Massachusetts. Dr. Kaban is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Fibrous Dysplasia, Cherubism, Mouth Sores, Osteotomy, and Bone Graft.

Frequently Asked Questions about Dr. Min K. Kim

How do I make an appointment with Dr. Min K. Kim?

You can book an appointment with Dr. Min K. Kim by calling their office at 978-851-5200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Min K. Kim a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Min K. Kim is classified as an Distinguished expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Min K. Kim specialize in?

While Dr. Min K. Kim is a Oral and Maxillofacial Surgery, they have specific expertise in Febrile Neutropenia, Menopause, and PIK3CA-Related Overgrowth Spectrum. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oral and Maxillofacial Surgery.

Does Dr. Min K. Kim participate in research or clinical trials?

Yes. Dr. Min K. Kim has published 524 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Dr. Min K. Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Min K. Kim accept my insurance?

Dr. Min K. Kim accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 978-851-5200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kim's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile